VAERS reports by lot

Novartis Vaccines Meningococcal lot TH9NR: VAERS reports

36 VAERS reports list lot TH9NR as a Novartis Vaccines Meningococcal vaccine, received between 2023-08-03 and 2024-11-08. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
36
Reports
0%
Marked serious
0
With a death outcome
10
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
Neurological1024%
General / Systemic (non-local)717%
Cardiac / Cardiovascular614%
Allergic / Anaphylactic614%
Dermatological (non-injection-site)512%
Musculoskeletal410%
Injection-site / Local reaction37%
Gastrointestinal12%

Where reports came from

U.S. state of the reporter, where given (top 12).

Idaho19
Michigan3
Texas2
California2
Wisconsin1
Florida1
Kansas1
Utah1
Oklahoma1
Connecticut1
Indiana1
Washington1

Reports by month received

2023-085
2023-101
2023-121
2024-011
2024-031
2024-051
2024-072
2024-083
2024-108
2024-1113

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.